Home About Events Articles Contact

Diabetes Research

Mentoring Programs

Education Centre

Saxenda Approved in the EU

An Injectable Weight-Loss Drug

According to Saxenda, an injectable weight-loss drug is now available for people which will help them to lose more weight than what they would lose through exercising or dieting. This drug is known as Liraglutide and is already being sold across Europe as a treatment for type 2 diabetes; however, it will now be approved to be sold in larger doses under the brand name Saxenda specifically for weight loss. Saxenda is, therefore, the new weight loss medication that is about to be launched in the EU and also in the US that will be used in combination with dieting and exercise that will help those that are obese and suffering from weight-related conditions to lose weight faster. Trials were conducted on obese patients who were unable to walk and we’re sitting in wheelchairs and using this drug they were able to lose so much weight that they were able to abandon their wheelchairs and walk normally. According to the makers of this drug, Novo Nordisk of Denmark, the drug also produces a feel-good factor” which makes dieting and exercising a pleasure for the user thus enhancing the entire weight loss process.

The Theory behind Saxenda

Saxenda works by regulating appetite by inducing a feeling of fullness and by reducing hunger pains. The drug is injected on a daily basis before breakfast. Once it gets into the body, it will work on the hormone in the stomach that sends signals of hunger to the brain. The drug will trick this hormone into sending signals of fullness instead thus resulting in the user not feeling hungry. It is expected that the user will eat ten percent less than what he would without the drug. 

The drug will only be offered to adults with a body mass index of more than 30 or between 27 and 30 if they are suffering from weight-related health conditions such as high blood pressure, high cholesterol or type 2 diabetes. Patients will receive a daily dosage of 3mg for twelve weeks and it is expected that their body weight will be reduced by at least five percent. If it does not they should stop treatment.

Liraglutide already on the Market

Liraglutide is already been sold on the market but in smaller doses and under the brand name Victoza. It was already approved as a treatment for type 2 diabetes. However, in its current form, it should not be used as a weight-loss drug and cannot be legally purchased as a weight-loss drug. It has only been approved as a treatment for type 2 diabetes. There are other aspects that need to be taken into consideration which is why the drug now has to be approved as a weight-loss drug and will be marketed under another brand that will be specifically for weight loss. It is important that users do not use drugs interchangeably. Victoza should not be used for weight loss and Saxenda should not be used for type 2 diabetes.

Purchasing Victoza and Saxenda

Victoza can already be purchased from The Online Clinic and since Saxenda has been approved and arrive on the market, The Online Clinic will also be prescribing this drug-taking into consideration the regulations pertaining to selling and using it. Saxenda even has the EMA trials. The European Medicines Agency is recommended that this drug be given marketing authorization as a weight loss product so it wouldn’t be long until this drug becomes available at The Online Clinic and other online healthcare providers.

Important Facts about Saxenda

All details pertaining to Saxenda and its usage can be found on FDA website; however, here are a few interesting facts that you should know about Saxenda before using it.

 It should not be used with insulin.

 It should be used in combination with exercise and dieting.

 It should not be used in combination with any other GLP-1 receptor agonist.

 It should not be used during pregnancy.

 Its effects on patients with a history of pancreatitis have not yet been studied.

 Some common side effects are headaches, vomiting, nausea, diarrhea, fatigue, and dizziness.

Get Advice From Doctors

As this drug as become available on the market now, it is advisable that you seek professional advice before using it. Visit your doctor and inform him or her of your desire to try this drug in an attempt to lose weight and get professional advice. You can also be guaranteed that you will receive quality information and advice from the manufacturer so you should also check out that site.  Speak to a doctor or other healthcare provider regarding the proper use of this drug in your attempt to lose weight and regain control of your life. 

FAD’s Advisory Panel Approves Liraglutide

In November 2008, Novo Nordisk initiated a PIII clinical trial of liraglutide for the treatment of obesity. After conducting a series of EMA trials and overcoming major and minor set-backs, the drug has finally received a positive assessment from the advisory panel of the FDA with a vote of 14-1 in favor of the drug’s approval as a treatment for obesity. This drug which will be sold under the name Saxenda if approved as a treatment for obesity is currently available in the United Kingdom but is known to diabetics by the name Victoza as it is already licensed in the United Kingdom as a treatment for Type 2 diabetes. 

Diabetes which is one of the leading causes of death and disability in the world is the result of glucose building up in the blood due to the pancreas not producing sufficient insulin which is the hormone that regulates the amount of sugar that builds up in the blood. As Victoza, the drug is intended to lower blood sugar levels when used in combination with exercise, a proper diet, and other selected diabetes medicines. Victoza is classified as a glucagon-like peptide-1 (GLP-1) receptor agonists and as such, it helps the pancreas in our body to produce more insulin after eating a meal in order to prevent glucose from building up in the blood. The most common side effects observed resulting from the use of Victoza are diarrhea, headache & nausea.

Difference between Victoza and Saxenda

So what exactly is the difference between Victoza and Saxenda? Why does the FDA need to approve liraglutide again if it has already been approved? Why is a new name necessary? Well, first of all, the main difference between Victoza and Saxenda is that Victoza has been approved as a 1.8mg per day dose for diabetes. It is prescribed by doctors and can be purchased online, but only at 1.8 mg per day maximum. Saxenda, on the other hand, will be for 3.0 mg per day. Although Victoza materials say that the drug may help you to lose weight, it is not indicated as a weight-loss drug and if it were to be sold as a weight loss drug it would go against the FDA’s label. This is the main difference between the two drugs and why a new name was needed. Some may wonder if it is necessary to purchase Saxenda when you can double the dosage of Victoza. Well, this is not advisable and it is definitely not an option. Doubling the Victoza dosage would be exceeding the 3mg dosage of Saxenda. Instead of a 3mg dosage, you will be taking a 3.6mg dosage if you choose to double the Victoza dosage.

Although the advisory panel of the FDA has voted in favor of Saxenda, approval by the FDA is not assured; however, it is expected by October. One of the reasons why the FDA’s approval is not assured as yet is the fact that plenty of concerns are still linked to the drug. The trials have revealed that the use of the drug has resulted in rare cases of pancreatitis and that it can increase the risks of thyroid and breast cancer. However, if this drug is approved as a treatment for obesity, Bloomberg reports that it could bring in $556 million in sales by 2018. Novo Nordisk, however, believes that there is sufficient potential for the drug on the market and that the estimated sales as reported by Bloomberg can be doubled. As stated by Mads Krogsgaard Thomsen, the chief science officer of Novo Nordisk, the potential patient group for Saxenda is very large as it will not be targeting obese people alone but those who are overweight as well and are suffering from complications resulting from them being overweight. The panel members who voted in favor of this drug also believes that if it is approved, the risks of using it could be further explored and will require Novo Nordisk to conduct more studies. 

It is a fact that the incidence of obesity has risen dramatically in recent years. There are only a few drugs that are safe and effective on the market, which can be used against obesity. Saxenda can definitely make a difference and can help people to lose weight and live healthier lives. If you would like to have more information on the clinical trials of liraglutide. You can also find information about this drug, its uses and what can be expected of it if it is officially approved by the FDA as a treatment for obesity. 

Recent News & Education

Saxenda Approved In The EU

Saxenda Approved In The EU


Diabetes Foundation

PMS Foundation
48 Belle Vue Terrace, Malvern
Email: support@pmsfoundation.org.uk